Список использованных источников

Главная страница
Контакты

    Главная страница



Список использованных источников



страница15/15
Дата12.01.2017
Размер2.31 Mb.
ТипОтчет


1   ...   7   8   9   10   11   12   13   14   15

Список использованных источников





  1. Аббасова С.Г., Липкин В.М., Трапезников Н.Н., Кушлинский Н.Е. Система FAS–FASL в норме и патологии // Вопр. биол., мед., фарм. химии. – 1999. –№ 3. – С. 3–17

  2. Апросина З.Г.Апоптоз//Русск. мед. журн.- 1996. -T.4.-N 3. -с. 174-177

  3. Аруин Л.И. Апоптоз и патология печени // Рос.журн. гастроэнтерол., гепатол., колопроктол. – 1998.– Т. 8, № 2. – С. 6–10

  4. БарановА.А., Б.С. Коганов, В.Ф. Учайкин и др Диагностика и лечение хронических вирусных гепатитов В, С,D у детей.//Вопр. соврем. педиатрии.-2004.-№6.-С.35-38

  5. Барышников. А.Ю. , Шишкин Ю.В. Иммунологические проблемы апоптоза //Москва.-2002. - С. 327

  6. Баснакьян А.Г., Басков А.В., Соколов Н.Н., Борщенко И.А. Апоптоз при травматическом повреждении спинного мозга: перспективы фармакологической коррекции// Вопросы медицинской химии.- 2000.- № 5

  7. Белецкий И.П., Сорокина О.В., Никонова Л.В. Генная терапия на основе системы Fas-aHTHreH-Fas-лиганд // Вопросы биологической медицинской и фармацевтической химии - 1999. - №4. - С. 40-49

  8. Белушкина Н.Н.. Особенности регуляции апоптоза при опухолевых, вирусных и аутоиммунных заболеваниях. Автореф. дис..доктора биол. наук.-М., 2005.- С. 32

  9. Буеверов А.О., Тихонина Е.В., Москалева Е.Ю. и др. Апоптоз периферических лейкоцитов при хронических вирусных гепатитах // Росс. ж. гастроэнтерол., гепатол., колопроктол. - 2000. - №6. - С. 30-33

  10. Вирусные гепатиты: Клиника, диагностика, лечение (под ред. Лобзина Ю.В.),2003-СПб:»Фолиант». С. 125

  11. Владимирская Е.Б., Масчан А.А., Румянцев А.Г. Апоптоз и его роль в развитии опухолевого роста. Гематол трансфузиол 1997; 5: С. 4-9

  12. Волчек И.В., Нестеров Н.Н., Сологуб Т.В., Белопольская М.А., Александрова В.И., Иванова В.В. Опыт использования препаратов рекомбинантных интерферонов для индивидуализированной монотерапии больных с хроническим гепатитом С. Terra med.. 2003, N 2, С. 3-5

  13. Дмитриева Е.В Дмитриева и др .Роль системы Fas/Fasl в индукции апоптоза гепатоцитов при хронических вирусных гепатитах . // Архив патологии. - 2003. - N 6. - С. 13-17

  14. Ершов Н.Н. и др. Интерфероновый статус пациентов с герпетической инфекцией// Цитокины и воспаление.- 2004.- Т.4.- № 1.- С. 5-8

  15. Жданов Р.И. Генная терапия: надежды и реалии // Вопросы биологической, медицинской и фармацевтической химии. - 1999. - №4. - С. 3-б

  16. Змызгова А.В., Москалева Е.Ю., Максимов С.Л, и др. Структура ДНК лейкоцитов периферической крови и показатели клеточного иммунитета больных вирусным гепатитом В // Вопросы биологической, медицинской и фармацевтической химии. -1999, №2, С. 16-19

  17. Исаков В.А. Герпетическая инфекция\\Наука.-2007.- С. 237

  18. Кетлинский С.А., Калинина Н.М. Цитокины мононуклеарных фагоцитов в регуляции реакции воспаления и иммунитета// Иммунология.- 1995.- № 3.- С. 30-44

  19. Князькин И.В., Цыган В.Н. Апоптоз в онкоурологии\\Наука.- 2007.- С. 237

  20. Козлов В.А. Некоторые аспекты проблемы цитокинов// Цитокины и воспаление.- 2002.- Т.1.- № 1.- С. 5-8

  21. Котович М. М. Роль этиотропной и патогенетической терапии в клинической и морфологической эволюции хронических гепатитов у детей. Автореф. дисс...докт. мед. наук. М., 2003 – С. 27

  22. Лесков В. П., Чередеев А. Н. и др. Клиническая иммунология для врачей – М.: Фармарус Принт, 1997.- С. 297

  23. Лушников Е.Ф., Абросимов А.Ю. Сравнительная морфология апоптоза и некроза клеток опухолей. Тезисы 1 Белорусского съезда патологоанатомов и судебных медиков. Минск 1990-1991; 2: 299-300.

  24. Маянский А.Н. Лекции по иммунологии.-Нижний Новгород: НГМА,2005.-2 С. 70

  25. Маянский А.Н., Маянский Н.А., Абаджиди М.А., Заславская М.И. Апоптоз: начало будущего. Ж микробиол 1997; 2: С. 88-94

  26. Метелица И.С. Иммунологический фенотип лимфоцитов периферической крови при патологии женской репродуктивной системы. Дис. ... канд. мед. наук. М 1996; С. 95

  27. Нестерова М.В., Чо-Чанг Ю.С., Северин Е.С. Роль антисмысловых олигонуклеотидов в регуляции клеточных процессов. // Вопросы биологической, медицинской и фармацевтической химии. - 1998. - №4. С.3-14

  28. Новиков В.В., Барышников А.Ю., Караулов А.В. Растворимые формы мембранных антигенов клеток иммунной системы. Иммунология. 2007; 4: С. 249–253.

  29. Новиков В.В., Евсегнеева И.В., Караулов А.В., Барышников А.Ю. Растворимые формы мембранных антигенов клеток иммунной системы при социально-значимых заболеваниях. Сообщение II. Исследование их роли при вирусных инфекциях. Рос. биотерапевтический журнал. 2005; 3: 1 С. 31–142

  30. Новожилова А.П., Плужников Н.Н., Новиков В.С. и др. Программированная клеточная гибель. СПб: Наука 1996; С. 276

  31. Райхлин Н.Т., Смирнова Е.А., Перевощиков А.Г. Апоптоз и его роль в механизмах регуляции роста опухолевых клеток с множественной лекарственной устойчивостью. Арх патол 1996; 2: С. 3-8

  32. Рахманова А.Г., Яковлев А.А., Виноградова Е.Н.//Хронические вирусные гепатиты,- С.Пб.-1997. - С. 29

  33. Рейзис А.Р., Н.В.Матанина, Д.А.Шмаров. Апоптоз лимфоцитов периферической крови в патогенезе вирусных гепатитов и антиапоптотическое действие урсодезоксихолевой кислоты.// Ж.Инфекционные болезни, г. Москва, 2006г., № 2, С. 5-9

  34. Робинсон М.В., Труфакин В.А. Апоптоз клеток иммунной системы. Успехи соврем биол. 1991; 111: 2: С. 246-259

  35. Романенко А.М. Апоптоз и рак. Арх патол 1996; 3: С. 18-22

  36. Северин СЕ. Биохимия и медицина - новые подходы и достижения. - М.: Русский врач, 1998.- С. 96

  37. Сек Ок Сун, Шапиро И.Я. Цитокиновый статус при различных вариантах течения цирроза печени. //Российский журнал гастроэнтерологии, гепатологии, колопроктологии. - 2002. - ХХII том. - С. 28

  38. Селицкая Р.П., Богодельникова И.В., Конова И.А. и др. Оценка экспрессии активационных маркеров на клеточных элементах очага туберкулезного воспаления в легком. Туберкулез и экология 1996; 2: С. 37-39

  39. Скрипкин Ю.К. и др. Инфекции, передаваемые половым путем.-Медпресс.-2001.- С. 202-212

  40. Сладкова Л. В., Москалева Е. Ю., Посыпанова Г. А. и др. Устойчивость В-клеточных линий человека с разным уровнем экспрессии Вс1-2 к противоопухолевым препаратам / / Вопр. биол., мед. и фарм. химии. — 2000. — № 3. —С. 25-29

  41. Соринсон С.Н. Вирусные гепатиты.-СПб:Фолиант,1997.- С. 174

  42. Сыркин А.Б., Герасимова Г. К., Барышников Ю. А. и соавт. Экспериментальная химиотерапия злокачественных опухолей на современном этапе. Вопр онкол 1995; 2: С. 41-45

  43. Тотолян А.А., Фрейдлин И.С. Клетки иммунной системы.- СПб.:Наука, 2000. - С. 231

  44. Умнова Н.В., Москалева Е.Ю., Порошенко Г.Г. Репарация ДНК у больных хроническими неспецифическими воспалительными заболеваниями легких. Бюлл экспер биол и мед 1986; 107: 12: С. 743-745

  45. Фрейдлин И.С.Проблемы апоптоза //Тихоокеанский медицинский журнал. - 1999. - №3. - С. 6-10

  46. Хоменко А.Г., Ковальчук Л.В., Мишин В.Ю. и др. Повышенный апоптоз иммунокомпетентных клеток как один из возможных механизмов в развитии иммунодефицита у больных остропрогрессирующим туберкулезом. Пробл туб 1996; 6: С. 6-10

  47. Чередеев А.Н., Ковальчук Л.В. Патогенетический принцип оценки иммунной системы человека: современные проблемы. Сб. трудов "Современные проблемы аллергологии, клинической иммунологии и иммунофармакологии", 1-я нац. конф. Росс. ассоц. аллергологов и клинических иммунологов. М 1997; С. 74-80

  48. Шахгильдян И.В., Михайлов М.И., Хухлович П.А., Ершова О.Н. с соавт. Современная эпидемиологическая характеристика парентеральных вирусных гепатитов (гепатитов В и С) в Российской Федерации.// В кн.: «Вирусные гепатиты – проблемы эпидемиологии, диагностики, лечения и профилактики»: Тез. докл. VI всеросс. научно-практ. конференции. – М., 24-25 мая 2005.– С. 380–384

  49. Ярыгин В.Н., Кораблев А.В. Значение программированной гибели эндотелия в построении внутриорганного кровеносного русла в эмбриогенезе человека. Арх патол 1995; 6: С. 39-44

  50. Ackerman R.C., Johnson G.A., Van-Kirk E.A. et al. Induction of apoptotic or lytic death in an ovarian adenocarcinoma cell line by antibodies generated against a synthetic N-terminal extracellular domain gonadotropin-releasing hormone receptor peptide. Cancer Lett 1994; 81: 2: P. 177-184

  51. Ackermann Е. J., Taylor J. К., Narayana R. et al. The role of antiapoptotic Bcl-2 family members in endothelial apoptosis elucidated with antisense oligonucleotides // The journal of biological chemistry. -1999. -Vol. 274.- N. 16.-P. 11245-11252

  52. Adrain C, Creagh E. M., Martin S. J. Apoptosis-associated release of Smac/DIABLO from mitochondria requires active caspases and is blocked by Bcl-2 // The EMBO journal.- 2001. - Vol. 20. - N. 23. - P. 6627-6636

  53. Akshay KV., Oriinick J R. The molecular basis for apoptotic defects in patients with CD95 (Fas/Apo-1) mutations// J Clin Invest. - 1999. - Vol. 103, №. 3. - P. 355-363

  54. Al Maini MH., Mountz JD., AlMohri HA., et a]. Serum levels of soluble Fas correlate with induces of organ damage in systemic lupus erythematosus// Lupus. - 2000. - Vol. 9. -P.132-139

  55. Almawi W.Y., Melemedjian O. K., and Abou Jaoude M. M On the link between Bcl-2 family proteins and glucocorticoid-induced apoptosis // J. Leukoc. Biol. - 2004, -V. 76. -P. 7-14

  56. Alonso С L., C. Alonso Hardcover Viruses & Apoptosis By / March 2004

  57. Ambar B.B., Frei K., Malipiero U. et al. Treatment of experimental glioma by administration of adenoviral vectors expressing Fas ligand //Hum Gene Ther.-1999,- V. 10.-P. 164-1-1648

  58. Andrade F., Casciola-Rosen L., Rosen A. apoptosis in systemic lupus erythematosus. Clinical implications// Rheum Dis Clin North Am. - 2000. - Vol.26. - P.215-227

  59. Antonsson B. Bax and other pro-apoptotic Bcl-2 family "killer-proteins" and their victim the mitochondrion // Cell Tissue Res. - 2001. - Vol. 306. - N. 3. - P. 347-361

  60. Antonsson В., Montessuit S., Sanchez B. et al. Bax is present as a high molecular weight oligomer/complex in the mitochondrial membrane of apoptotic cells // The journal of biological chemistry.-2001.-Vol. 276.-N. 15-P. 11615-11623

  61. Aoki K., Akyurek L.M., San H., et al. Restricted expression of an adenoviral vector encoding Fas ligand (CD95L) enhances safety for cancer gene therapy// Mol Ther. — 2000.-V.I.-P. 555-565

  62. Arafat W.O., Gomez-Navarro J., Xiang J. et al. An adenovirus encoding proapoptotic Bax induces apoptosis and enhances the radiation effect in human ovarian cancer// Molecular Therapy.-2000.-V.l.-P. 545-554

  63. Aral H., Gordon D., Nabel E. G., Nabel G. J. Gene transfer of Fas ligand induces tumor regression in vivo // Proc. nat. Acad. Sci. USA. - 1997. - Vol. 94, N 25. - P. 13862-13867

  64. Arends M. J., Wyllie A. H. Apoptosis. Mechanism and role in pathology // Inlern. Rev. Exp. Pathol. -1991. - Vol.32. - P.223-254

  65. Aschoff A. P., Ott U., Funfstuck R. et al. Colocalisation of Bax and Bcl-2 in small intestine and kidney biobsies with different degrees of DNA fragmentation // Cell Tissue Res.-1999.-Vol. 296.-P. 351-357

  66. Ashkenazi A., Pai, R.C., Fong S. et al. Safety and antitumor activity of recombinant soluble Apo2 ligand// Clinical Investigation. - 1999.- V. 104. -P. 155-162

  67. Bamberger A.M., Schulte H.M., Thuneke I. et al. Expression of the apoptosis-inducing Fas ligand (FasL) in human first and third trimester placenta and choriocarcinoma cells. J Clin Endocrinol Metab 1997; 82: 9: 3173-3175

  68. Banner DW, D'Arcy A, Janes W et al. Crystal structure of the soluble human SS kd TNF receptor-human TNF beta complex: implications for TNF receptor activation.- Cell.-1993.-V.73.-P. 431-445

  69. Bantel H., Lugering A., Poremba C. et al. Caspase activation correlates with the degree of inflammatory liver injury in chronic hepatitis C virus infection //Hepatology. – 2001. – Vol. 34. – P. 758–767

  70. Bardelli A. HGF receptor associates with the anti-apoptotic protein Bag-1 and prevents cell death // The EMBO journal. -1996. - Vol. 15. - P. 6205-6212

  71. Basaflez G., Nechushtan A., Drozhinin 0. et al. Bax, but not Bcl-XL, decreases the lifetime of planar phospholipid bilayer membranes at subnanomolar concentrations // Proc. Natl. Acad. Sci. USA. - 1999. - Vol. 96. - N. 10. - P. 5492-5497

  72. Basanez G., Zhang J., Chau B. N. et al. Pro-apoptotic cleavage products of Bcl-XL form cytochrome c-conducting pores in pure lipid membranes // The journal of biological chemistry. - 2001. - Vol. 276. - P. 31083-31091

  73. Batteux F., Tourneur L, Trebeden H. et al. Gene therapy of experimental autoimmune thyroiditis by in vivo administration of plasmid DNA coding for Fas ligand // J. Immunol. — 1999. — Vol. 162, N 1. - P. 603-608

  74. Baumann H., Gearing D., Ziegler S. F. Signaling by the cytoplasmic domain of hematopoietin receptors involves two distinguishable mechanisms in hepatic cells // J. Biol. Chem. — 1994.- Vol. 269, N 23. - P. 16297-16304

  75. Bell C.G. Apoptosis in T and B lymphocytes life cycles. Biochim Soc Trans 1995; 23: 2: P. 214

  76. Bellgrau D., Gold D., Selawry H. et al. A role for CD95 ligand in preventing graft rejection // Nature. — 1995. — Vol. 377, N 6550. - P. 630-632

  77. Bennett M.R. Apoptosis in the cardiovascular system// Heart,- 2002.-V. 87.- № 5.-P. 480-487

  78. Berke G. Killing mechanisms of cytotoxic lymphocytes. Curr Opin Hematol 1997; 4: P. 32-40

  79. Berman M. L, Silhavy T. J., Enquist L. W. Experiments with gene fusions. —New York, 1984

  80. Biswas S. K., Huang J., Persaud S., and Basu A. Down-regulation of Bcl-2 is associated with cisplatin resistance in human small cell lung cancer H69 cells //Mol. Cancer Ther,-2004. -V.3. -P. 327-334

  81. Bodmer J. TRAIL receptor-2 signals apoptosis through FADD and caspase-8 //Nature Cell Biology. - 2000. - V. 2.- P. 241-243

  82. Botarelli P., Brunetto M.R., Minutello M.A. et al.T-cell response to hepatitis C virus in different clinical courses of infection // Gastroenterology. – 1993. – Vol. 194. – P. 580–587

  83. Boueverov A.O., Mammaev S.N., Tikhonina E.V. et al. Enchanced apoptosis of peripheral blood leucocytes in chronic viral hepatitis // Gut. - 2000. - Vol.47 (suppl. 3). - P. 181

  84. Bu S.Z., Yin D.L., Ren X.H. et al. Progesterone induces apoptosis and up-regulation of p53 expression in human ovarian carcinoma cell lines. Cancer 1997; 79: 10: P. 1944-1950

  85. Burke F., East N., Upton C. et al. Interferon gamma induces cell cycle arrest and apoptosis in a model of ovarian cancer: enhancement of effect by batimastat. Eur J Cancer 1997; 33: 7: P. 1114-1121

  86. Butz K., Geisen C., Ullmann A. et al. Cellular responses of HPV-positive cancer cells to genotoxic anticancer agents: repression of E6/E7-oncogene expression and induction of apoptosis. Int J Cancer 1996; 68: 4: P. 506-513

  87. Calabrese F., Pontiso P., Perrenazzo E. et al. Liver cell apoptosis in chronic hepatitis C correlates but not biochemical activity or serum HCV-RNA levels// Hepatology. – 2000. – Vol. 31. – P. 1153–1159

  88. Chen W., Liu Y., Glund C. Bile acids for viral hepatitis , 2003. Cochrane Database Syst Rev 2003, (2).-P.1256-1264

  89. Chen Z., Naito M., Mashima T., Tsuruo T. Activation of actin-cleavable interleukin 1beta-converting enzyme (ICE) family protease CPP-32 during chemotherapeutic agent-induced apoptosis in ovarian carcinoma cells. Cancer Res 1996; 56: 22: P. 5224-5229

  90. Cohen G.M. Caspases: the executioners of apoptosis //Biochem. J. – 1997. – Vol. 326. – P. 1–16

  91. De Angelis P.M., Stokke Т., Thorstensen L. et al. Apoptosis and expression of Bax, Bcl-X, and Bcl-2 apoptotic regulatory proteins in colorectal carcinomas, and association with P53 genotype/phenotype // Mol. Pathol. - 1998. - Vol. 51. - N. 5. - P. 254-261

  92. Debernardis D., Sire E.G., De-Feudis P. et al. p53 status does not affect sensitivity of human ovarian cancer cell lines to paclitaxel. Cancer Res 1997; 57: 5: P. 870-874

  93. Deshane J., Grim J., Loechel S. et al. Intracellular antibody against erbB-2 mediates targeted tumor cell eradication by apoptosis. Cancer Gen Ther 1996; 3: 2: P. 89-98

  94. Diebold J., Baretton G., Felchner M. et al. bcl-2 expression, p53 accumulation, and apoptosis in ovarian carcinomas. Am J Clin Pathol 1996; 105: 3: P. 341-349

  95. Dutton G. Debating Gene Therapy's Future // Genetic Engineering News. - 2000. -V.20. -№1

  96. Eissa S., Seada L.S. Quantitation of Bcl-2 protein in bladder cancer tissue by enzyme immunoassay: comparison with Western blot and immenohistochemistry // Clinical chemistry. - 1998. - Vol. 44. - N. 7. - P. 1423-1429

  97. Eliopoulos A.G., Kerr D.J., Herod J. et al. The control of apoptosis and drug resistance in ovarian cancer: influence of p53 and bcl-2. Oncogene 1995; 11: 7: P. 1217-1228

  98. Eskes R., Antonsson B.,Osen-Sand A. et al, Bax-induced cytochrome с release from mitochondria is independent of the permeability transition pore but highly dependent on Mg2+ ions // The journal of cell biology. -1998. - Vol. 143. - P. 217-224

  99. Eskes R., Desagher S., Antonsson B. Bid induces the oligomerization and insertion of Bax into the outer mitochondrial membrane // Molecular and cellular biology. - 2000. -Vol. 20. -N.3.- P. 929-935

  100. Fadok V.A., Bratton D.L., Henson P.M. Phagocyte receptors for apoptotic cells: recognition, uptake, and consequences// J. CHn. Invest,- 2001.-V. 108.-№7.- P. 957-962

  101. Fajac A., Da-Silva J., Ahomadegbe J.C. et al. Cisplatin-induced apoptosis and p53 gene status in a cisplatin-resistant human ovarian carcinoma cell line. Int J Cancer 1996; 68: 1: P. 67-74

  102. Fan X.G., Liu W.E., Li C.Z. et al. Circulating Th1 and Th2 cytokines in patients with hepatitis C virus infection// Mediators Inflamm. – 1998. – Vol. 7. – P. 295–297

  103. Farid P., Gomb S.Z., Peter I. et al. Bcl-2, p53 and Bax in thyroid tumors and their relation to apoptosis // Neoplasma. - 2001. - Vol. 48. - N. 4. - P. 299-301

  104. Faubion W.A., Gores G.J. Death receptors in liver biology and pathobiology // Hepatology. – 1999. – Vol. 29. – with histological P. 1–4

  105. Ferrandina G., Melichar B., Loercher A. et al. Growth inhibitory effects of sodium phenylacetate (NSC 3039) on ovarian carcinoma cells in vitro. Cancer Res 1997; 57: 19: P. 4309-4315

  106. Ferraro E., Corvaro M., Cecconi F. Physiological and pathological roles of Apafl and apoptosome// J.Cell.MoLMed.- 2003.- V.7.-P. 21-34

  107. Feudis P., Vignati S., Rossi C, et al,, Driving p53 response to Bax activation greatly enhances sensitivity to taxol by inducing massive apoptosis.//Neoplasia. - 2000. - Vol.2. - P.202-207

  108. Filippovich I.V., Sorokina N.I., Robillard N., Chatal J.F. Radiation-induced apoptosis in human ovarian carcinoma cells growing as a monolayer and as multicell spheroids. Int J Cancer 1997; 72: 5: P. 851-859

  109. Finucane D. M., Bossy-Wetzel E., Waterhouse N. J. et al. Bax induced caspase activation and apoptosis via cytochrome с release from mitochondria is inhibitable by Bcl-XL // The journal of biological chemistry. - 1999. - Vol. 274. - N. 4. - P. 2225-2233

  110. Frankel A., Buckman R., Kerbel R.S. Abrogation of taxol-induced G2-M arrest and apoptosis in human ovarian cancer cells grown as multicellular tumor spheroids. Cancer Res 1997; 57: 12: P. 2388-2393

  111. Furuya H., Yabushita H., Noguchi M., Nakanishi M. Apoptosis and cell growth fraction in normal, dysplastic and neoplastic squamous epithelium of uterine cervix. Nippon Sanka Fujinka Gakkai Zasshi 1995; 47: 2: P. 141-148

  112. Galle P.R., Hofmann W.I.,Walczak H. et al. Involved of the CD 95 (APO-1/Fas) receptor and ligand in liver damage J. Exper. Med. —1995. —182. —Р. 1223-1230

  113. Gamnann A., Tews D.S., Mayer E. et al. Expression of apoptosis-related proteins, p53, and DNA fragmentation in sarcomas of the pulmonary artery // Cancer. - 2001. - Vol. 92.-N. 5. -P. 1237-1244

  114. Garzetti G.G., Ciavattini A., Provinciali M. et al. Expression of p53 and apoptosis of tumor cells in locally advanced cervical carcinoma after cisplatin based neoadjuvant chemotherapy. Anticancer Res 1996; 16: 5B: 3229-3234

  115. Gibb R.K., Taylor D.D., Wan T. et al. Apoptosis as a measure of chemosensitivity to cisplatin and taxol therapy in ovarian cancer cell lines. Gynecol Oncol 1997; 65: 1: P. 13-22

  116. Golstein P. Controlling cell death// Sceince 1997, v.275, P. 1081-1082

  117. Gong В., Chen Q., Endlich B. et al. Ionizing radiation induced Bax mediated cell death is dependent on activation of cysteine and serine proteases // Cell Growth & Differentiation. -1999.-Vol. 10. -P. 491-502

  118. Gotlieb W.H., Watson J.M., Rezai A. et al. Cytokine-induced modulation of tumor suppressor gene expression in ovarian cancer cells: up-regulation of p53 gene expression and induction of apoptosis by tumor necrosis factor-alpha. Am J Obstet Gynecol 1994; 170: 4: P. 1121-1128 (discussion 1128-1130)

  119. Griffith T.S., Anderson R.D., Davidson B.L., Williams R.D., and Ratliff, T.L, Adenoviral-mediated transfer of the TNF-related apoptosis-inducing ligand/Apo-2 ligand gene induces tumor cell apoptosis // Journal of Immunology. - 2000. - V. 165. - P. 2886-2894

  120. Griffith T.S., Brunner T., Fletcher S.M., Green D.R., Ferguson T.A. Fas ligand-induced apoptosis as a mechanism of immune privilege.// Science.- 1995.-V. 270.-P. 5239

  121. Griffith T.S., Brunner Т., Fletcher S.M., Green D.R. and Ferguson T.A. Fas Hgand-induced apoptosis as a mechanism of immune privilege// Science.- 1995.-V. 270.-P. 1189-1192

  122. Gross A., Jockel J., Wei M.C., Kosmeyer SJ. Enforced dimerization of Bax results in its translocation, mitochondria! disfunction and apoptosis. // EMBOj. - 1998. -Vol.17.- P. 3878-3885

  123. Gross A., McDonnell J. M., Korsmeyer S. J. Bcl-2 family members and the mitochondria in apoptosis // Genes Dev. - 1999. - Vol. 13. - N. 15. - P. 1899-1911

  124. Gu J., Zhang L,, Huang X., Lin T. et al. A novel single tetracycline-regulative adenoviral vector for tumor-specific Bax gene expression and cell killing in vitro and in vivo //Oncogene. -2002.-V. 18-21(31).-P. 4757-4764

  125. Guo Y., Srinivasula S. M., Druilhe A. et al. Caspase-2 induces apoptosis by releasing proapoptotic proteins from mitochondria // The journal of biological chemistry. - 2002. - Vol. 277. - P. 13430-13437

  126. Guo В., Godzik A., Reed Y.R. Bcl-G, a novel pro-apoptotic member of the Bcl-2 family // The journal of biological chemistry. - 2001. - Vol. 276. - N. 4. - P. 2780-2785

  127. Hardwick J.M. Virus-induced apoptosis // Adv. Pharmacol. -1997, v,41, P. 295-336

  128. Harris M. H., Heiden M. G. V., Kron S. J. et al. Role of oxidative phosphorylation in Bax toxicity // Molecular and cellular biology. - 2000. - Vol. 20. - N. 10. - P. 3590-3596

  129. Haunstetter A., Izumo S. Apoptosis: basic mechanisms and implications for cardiovascular disease// Circ. Res.- 1998-V. 82.- №11 .-P. l 111-1129

  130. Havrilesky L.J., Elbendary A., Hurteau J.A. et al. Chemotherapy-induced apoptosis in epithelial ovarian cancers. Obstet Gynecol 1995; 85: 6: P. 1007-1010

  131. Havrilesky L.J., Hurteau J.A., Whitaker R.S. et al. Regulation of apoptosis in normal and malignant ovarian epithelial cells by transforming growth factor beta. Cancer Res 1995; 55: 4: P. 944- 948

  132. Hay S., Kannourakts G. A time to kill: viral manipulation of the cell death program// J. Gen. Virol..- 2002.-V. 83.-P. 1547-1564

  133. Hayashi N., Mita E. Fas system and apoptosis in viral hepatitis // J. Gastroenterol. Hepatol. – 1997. – Vol.12. – P. 223–226

  134. Hayashi, N., E. Mita. Fas system and apoptosis in viral hepatitis. J, Gastroenterol. Hepatol. 12: S223-S226,1997

  135. Heatley M.K. A high apoptotic index occurs in subtypes of endometrial adenocarcinoma associated with a poor prognosis. Pathology 1997; 29: 3: 272-275

  136. Heatley M.K. Association between the apoptotic index and established prognostic parameters in endometrial adenocarcinoma. Histopathology 1995; 27: 5: 469-472

  137. Hedlund Т.Е., Meech S.J., Srikanth S., Kraft A.S., Miller G.J., Schaack J.B. and Duke R.C. Adenovirus-mediated expression of Fas ligand induces apoptosis of human prostate cancer cells //Cell Death Differ.- 1999.-V. 6. -P. 175-182

  138. Heiden M. G. V., Chandel N. S., Li X. X. et al. Outer mitochondrial membrane permeability can regulate coupled respiration and cell survival // Proc. Natl. Acad. Sci. USA. - 2000. - Vol. 97. - N. 9. - P. 4666-4671

  139. Hengarten O.M. The Biochemistry of apoptosis // Nature. - 2000. - Vol.407.-P.770-775

  140. Higashijima T., Kataoka A., Nishida T., Yakushiji M. Gonadotropin-releasing hormone agonist therapy induces apoptosis in uterine leiomyoma. Eur J Obstet Gynecol Reprod Biol 1996; 68: 1-2: 169-173

  141. Hiramatsu N., Hayashi N., Katayama K. et al. Immunohistochemical detection of Fas antigen in liver tissue of patient with chronic hepatitis C // Hepatology —1994. —19. —Р. 1354-1359

  142. Hirotani M., Zhang Y., Fujita N. et al. NH2-terminal BH4 domain of Bcl-2 is functional for heterodimerization with Bax and inhibition of apoptosis // The Journal of Biological Chemistry. - 1999. - Vol. 274. - N. 29. - P. 20415-20420

  143. Hoetelmans R.W..M, Slooten H-J, Keijzer R. et al. Bcl-2 and Bax proteins are present in interphase nuclei of mammalian cells. //Cell death and Different. - 2000, -Vol.7.-P.384-392

  144. Holler N., Tardivel A., Kovacsovics-Bankowski M. et al. Two adjacent trimeric Fas ligands are required for Fas signaling and formation of a death-inducing signaling complex // Molecular and Cellular Biology. - 2003. - Vol. 23. - N. 4. - P. 1428-1440

  145. Honda Т., Kagawa S., Spurgers K.B. et al. A recombinant adenovirus expressing wild-type Bax induces apoptosis in prostate cancer cells independently of their Bcl-2 status and androgen sensitivity// Cancer Biol. Ther. - 2002.- V.1(2).-P. 163-167

  146. Hsu Y.-T., Youle R. J. Nonionic detergents induce dimerization among members of the Bcl-2 family // The journal of biological chemistry. - 1997. - Vol. 272. - N. 21. -P. 13829-13834

  147. Huang D.C.S., Hahne M., Schroeter M et al. Activation of Fas by FasL induces apoptosis by a mechanism that cannot be blocked by Bcl-2 or Bcl-XL // Proc. Natl. Acad. Sci. USA. - 1999. - Vol. 96. - P. 14871-14876

  148. Huang D.C.S., O'Reilly L. A., Strasser A. et al. The anti-apoptosis function of Bcl-2 can be genetically separated from its inhibitory effect on cell cycle entry // The EMBO journal. - 1997. -Vol. 16. - N. 15. - P. 4628-4638

  149. Huang S.C., Chou C.Y., Lin Y.S. et al. Enhanced deoxyribonucleic acid damage and repair but unchanged apoptosis in uterine leiomyomas treated with gonadotropin-releasing hormone agonist. Am J Obstet Gynecol 1997; 177: 2: 417-424

  150. Huang X., Lin Т., Gu J. et al. Combined TRAIL and Bax gene therapy prolonged survival in mice with ovarian cancer xenograft //Gene Ther. - 2002.- V.9(20).-P.1379-1386

  151. Huh W.K., Gomez-Navarro J., Arafat W.O., Xiang J., Mahasreshti P.J., Alvarez R.D. Bax-induced apoptosis as a novel gene therapy approach for carcinoma of the cervix//! Gynecol Oncol. - 2001,- V.83(2).-P. 370-377

  152. Hunt K.K., Deng J., Liu T.J. et al. Adenovirus-mediated overex-pression of the transcription factor E2F-1 induces apoptosis in human breast and ovarian carcinoma cell lines and does not require p53. Cancer Res 1997; 57: 21: 4722-4726

  153. Hyer MX., Voelkel-Johnson C, Rubinchik S., Dong J, and Norris J.S. Intracellular fas ligand expression causes fas-mediated apoptosis in human prostate cancer cells resistant to monoclonal antibody-induced apoptosis // Mol Ther. - 2000. -V. 2.-P. 348-58

  154. Ilyas M., Нао X.P., Wilkinson K. et al. Loss of Bcl-2 expression correlates with tumour recurrence in colorectal cancer // Gut. - 1998. - Vol. 43. - N. 3. - P. 383-387

  155. Inohara N., Ekhterae D., Garcia I. et al. Mtd - a novel Bcl-2 family member activates apoptosis in the absence of heterodimerization with Bcl-2 and Bcl-XL // The journal of biological chemistry. - 1998. - Vol. 273. -N. 15. - P. 8705-8710

  156. Ionov Y., Yamamoto H., Krajewski S. et al. Mutational inactivation of the proapoptotic gene Bax confers selective advantage during tumor clonal evolution // Proc. Natl. Acad. Sci. USA. - 2000. - Vol. 97. - N. 20. - P. 10872-10877

  157. Isacson C., Kessis T.D., Hedrick L., Cho K.R. Both cell proliferation and apoptosis increase with lesion grade in cervical neoplasia but do not correlate with human papillomavirus type. Cancer Res 1996; 56: 4: 669-674

  158. Jansson A., Sun X.F, Bax expression decreases significantly from primary tumor to metastasis in colorectal cancer // J. Clin, Oncol. - 2002. - Vol. 20. - N. 3. - p. 811-816

  159. Jen-old S., Koh LS, The role of apoptosis in autoimmunity: Immunogen, antigen, and accelerant// Seminars in Nephrology. - 1999. -Vol.19. -P.34-47

  160. Jeremias, I, and Debatin, K.M. TRAIL induces apoptosis and activation of NF kappa В // European Cytokine Network. - 1998. - V. 9. -P. 687-688

  161. Jeremy McNally et al. Fas ligand expression and function in systemic lupus erythematosus. J. Immunol. 1997; 159: 4628-4636

  162. Johnson A. L. Editorial: Mcl-1 - just another antiapoptotic Bcl-2 homolog? // Endocrinology. - 1999. - Vol. 140. - N. 12. - P. 5465-5468

  163. Jonsson J.R., Edwards-Smith C.J., Catania S.C. et al. Expression of cytokines and factors modulating apoptosis by human sinusoidal leucocytes // J. Hepatol. - 2000. - Vol.32. -P.392-398

  164. Joyner A,L. Gene Targeting. Oxford. - 2003. - P. 293

  165. Ju S T. et al. Fas (CD95)/FasL interactions required for programmed cell death after activation. Nature 1995; P. 373-444

  166. Kagawa S., Pearson S.A., Ji L. et al. A binariy adenoviral vector for expressing high levels on the proapoptotic gene bax.// Gene Ther. - 2000. - Vol.7. - P.75-79

  167. Kagawa Sh., Gu J., Swisher S., et al. Antitumor effect of adenovirus-mediated Bax gene transfer on p53-sensitive and p53-resistant cancer lines. // Cancer Res. - 2000. -Vol.60.-P. 1157-1161

  168. Kaklamanis L., Savage A.f Whitehouse R. et al. Bcl-2 protein expression: association with p53 and prognosis in colorectal cancer // Br. J. Cancer. - 1998. - Vol. 77.-N. 11.-P. 1864-1869

  169. Kaliberov S.A., Buchsbaum D.J., Gillespie G.Y. et al. Adenovirus-mediated transfer of BAX driven by the vascular endothelial growth factor promoter induces apoptosis in lung cancer cells // Mol. Ther. ~ 2002.- V.6(2). - P. 190-198

  170. Kalkeri G, Khalap N, Garry RF et al. Hepatits С virus protein expression induced apoptosis in HepG2 cells//Virology 2001, 282(1), P. 26-37

  171. Kang P.M., Izumo S. Apoptosis and heart failure: A critical review of the literature// Circ. Res.- 2000.-V. 86.- № 11.-P. 1107-1113

  172. Kang S. M, Schneider D. ., Lin Z. et al. Fas- ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction//Nature Med. —1997. - Vol. 3, N 7. - P. 738-743

  173. Karlsson L., Leser G., Ryd W., Horvath G. Estradiol induces DNA fragmentation in a human endometrial adenocarcinoma with estradiol-inhibited growth phenotype. Anticancer Res 1997; 17: 5A: P. 3259-3263

  174. Kato N, Yoshida H, Kioko Ono-Nita S. et al. Activation of intracellular signaling by hepatitis В and С viruses: C-viral core is the most potent signal inducer/ZHepatology 2000, 32(2), P. 405-412

  175. Kawaguchi Y., Takebayashi H., Kakizuka A. et al. Expression of Fas-estrogen receptor fusion protein induces cell death in pancreatic cancer cell lines //Cancer Lett. — 1997. — Vol. 116.N 1. - P. 53-59

  176. Kawahara H., Matsuda Y., Takase S. Is apoptosis involved in alcoholic hepatitis? // Alcohol. Alcohol. –1994. – Vol. 29 (suppl. 1). – Р. 113–118

  177. Kerr Y.F.R., Wyllie A.H., Currie A.R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972; 26: 2: 239-257

  178. Kim C.Y., Tsai M.H., Osmanian C. et al. Selection of human cervical epithelial cells that possess reduced apoptotic potential to low-oxygen conditions. Cancer Res 1997; 57: 19: 4200- 4204

  179. Kim H, Lee H, Yun Y. X-gene product of hepatitis В virus induces apoptosis in liver cells//J Biol Chem 1998, 273(1), P. 381-385

  180. Kim T.-H., Zhao Y., Barber M. J. et al. Bid induced cytochrome с release is mediated by a pathway independent of mitochondrial permeability transition pore and Bax//The journal of biological chemistry.-2000. -Vol. 275. -N. 50. - P. 39474-39481

  181. Kirsch D.G., Doseff A., Chau B. N. et al. Caspase-3-dependent cleavage of Bcl-2 promotes release of cytochrome с // The journal of biological chemistry. - 2001. - Vol. 274.-N. 30.-P. 21155-21161

  182. Kleinman D., Douvdevani A., Schally A.V. et al. Direct growth inhibition of human endometrial cancer cells by the gonadotropin-releasing hormone antagonist SB-75: role of apoptosis. Am J Obstet Gynecol 1994; 170: 1: Pt 1: 96-102

  183. Klintman D.,X.Li, andH.Thorlacius Important Role of P-Selectin for Leukocyte Recruitment, Hepatocellular Injury, and Apoptosis in Endotoxemic Mice//Clin. Vaccine Immunol..- January 1.- 2004.-V.11(1).-P. 56 - 62

  184. Kluck R.M., Bossy-Wetzel E., Green D.R. et al. The release of cytochrome с from mitochondria: a primary she for Bcl-2 regulation of apoptosis // Science, - 1997. - Vol. 275.-P. 1132-1136

  185. Kountouras J., Chatzopoulos D., Zavos C. Apoptosis in hepatitis C // J. Viral Hepatitis. – 2003. – Vol. 10. – P. 335–342

  186. Krammer P. H. CD95's deadly mission in the immune system // Nature. - 2000. -Vol. 407. - P. 789-795

  187. Krueger A., Baumann S., Krammer P. H„ Kirchhoff S. FLICE-inhibitory proteins: regulators of death receptor-mediated apoptosis // Molecular and cellular biology. - 2001. - Vol. 21. - N. 24. - P. 8247-8254

  188. Kuwano K., Kunitake R., Kawasaki M. et al. P21/Cip/Sdi1 and p53 expression in association with DNA strand breaks in idiopathic pulnonary fibrosis. Am J Responce Crit Care Med 1996; 154: 477-483

  189. Kuwashima Y., Kobayashi Y., Kawarai A. et al. Apoptosis in human endometrial adenocarcinoma: comparison of nick end labeling and Le(y) antigen immunostaining method. Anticancer Res 1996; 16: 5B: 3225-3228

  190. Kuwashima Y., Kobayashi Y., Kawarai A. et al. Expression of bcl-2 and apoptotic DNA fragmentation in human endometrial adenocarcinoma cells. Anticancer Res 1996; 16: 5B: 3221- 3224

  191. Kuwashima Y., Kobayashi Y., Kawarai A. et al. Occurrence of apoptotic DNA fragmentation in quiescent and proliferating cells in human endometrial adenocarcinoma tissues and the influence of apoptosis-suppressing effects of bcl-2 products. Anticancer Res 1997; 17: 5B: 3737-3741

  192. Lafon C., Mathieu C., Guerrin M. et al. Transforming growth factor beta 1-induced apoptosis in human ovarian carcinoma cells: protection by the antioxidant N-acetylcysteine and bcl-2. Cell Growth Differ 1996; 7: 8: 1095-1104

  193. Lam M., Bhat M. В., Nunez G, et al. Regulation of Bcl-XL channel activity by calcium // The journal of biological chemistry. - 1998. - Vol. 273. - N. 28. - P. 17307-17310

  194. Levine E.L., Renehan A., Gossiel R. et al. Apoptosis, intrinsic radiosensitivity and prediction of radiotherapy response in cervical carcinoma. Radiother Oncol 1995; 37: 1: 1-9

  195. Li X. K., Okuyama ., Tamura A. et al. Prolonged survival of recipient rats with Fas-ligand-transfected liver allografts by using HVJ-liposome // Transplant. Proc. — 1998, —Vol. 30, N4

  196. Liang Y., Nylander K. D,, Yan C, Schor N. F. Role of caspase 3-dependent Bcl-2 cleavage in potentiation of apoptosis by Bcl-2 // Mol. Pharmacol. - 2002. - Vol. 61. - P. 142-149

  197. Lian-Jun Y., Wen-Liang W. Expression of Bcl-2 and Bax proteins in hepatocellular carcinoma tissue // J. Fourth Mil. Med. Univ. - 2002. - Vol. 23. - P. 337-340

  198. Liu X,-H., CasteUi J. C, Youle R. J. Receptor-mediated uptake of an extracellular Bcl-XL fusion protein inhibits apoptosis // Proc. Natl. Acad. Sci. USA. - 1999. - Vol.96. -N. 17.-P. 9563-9567

  199. Lock R. B, Bcl-2 inhibits a Fas induced conformational change in the Bax N-terminus and Bax mitochondrial translocation // The journal of biological chemistry. -2000. - Vol. 275. -N. 23. - P. 17225-17228

  200. Lorenz HM., Herrmann M, Winkler Т., et al. Role of apoptosis in autoimmunity//Apoptosis. - 2000. -Vol. 5. - P. 443

  201. Lynch DH., Ramsdell F., Alderson MR. Fas and FasL in the homeostatic regulation of immune responses// Immunol Today. -1995. -Vol. 16. - P.569

  202. MacFarlane M., Merrison W., Bratton S. B. et al. Proteasome-mediated degradation of Smac during fpoptosis: XIAP promotes Smac ubiquitination in vitro // The journal of biological chemistry. - 2002. - Vol. 277. - P. 36611-36616

  203. Marani M., Tenev Т., Hancock D, et al. Identification of novel isoforms of the BH3 domain protein Bim which directly activate Bax to trigger apoptosis // Molecular and cellular biology. - 2002. - Vol. 22. - N. 11. - P. 3577-3589

  204. Mathieu C., Jozan S., Mazars P. et al. Density-dependent induction of apoptosis by transforming growth factor-beta 1 in a human ovarian carcinoma cell line. Exp Cell Res 1995; 216: 1: 13-20

  205. McDonnel J., Bechm A., Sarkiss M. et al. Importance of the Bcl-2 family in cell death regulation// Experientia. - 1996. - Vol. 52. - P. 1008-1017

  206. Mita E, Hayashi N, Lio S et al. Role of fas ligand in apoptosis induced by hepatits С infection // Biochem. Boiphis. Res. Commun. - 1994. - 204. - P. 468-474

  207. Mitsades N., Poulaki V.t Tseleni-Balafouta S., Koutras D.A., and Stamenkovic L Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing Ligand // Cancer Research.- 2000.- V. 60. - P. 4122-4129

  208. Miyawaki T., Uehara T., Nibu R. et al. Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood. J Immunol 1992; 149: 3753-3758

  209. Mullauer L., Gruber P., Sebinger D. et al. Mutations in apoptosis genes: a pathogenetic factor for human disease // Mutat Res. - 2001. - Vol. 488. - N. 3. - P. 211-231

  210. Nagata S. Apoptosis by death factor // Cell. - 1997. - Vol. 88. - P. 355-365

  211. Nagata S. Fas ligand- induced apoptosis// Ann. Rev. Genet. - 1999. -Vol. 33. - P. 29-55

  212. Nagata,S. Apoptotic DNA fragmentation.// Exp. Cell Res.-2000.-V.- 256.-P. 12–18

  213. Narita M., Shimizu S., Ito T. et al. Bax interacts with the permeability transition pore to induce permeability transition and cytochrome с release in isolated mitochondria // Proc. Natl. Acad. Sci. USA. - 1998. - Vol. 95. - N. 25. - P. 14681-14686

  214. Nasir T., Arona H.S, Kaiser H.E. Apoptosis and pathogenesis of viral hepatitis C-an update in vivo.,2002.-Vol.14.-P.297-300

  215. Nauman U., M. Weller. Retroviral BAX gene transfer fails to sensitise malignant glioma cells to CD95L-induced apoptosis and cancer chemotherapy.// Int. J. Cancer. 1998. - Vol.77. - P.645-648

  216. Norris J.S., Hyer M.L., Voelkel-Johnson C. etal. The use of Fas Ligand, TRAIL and Bax in gene therapy of prostate cancer // Curr Gene Then- 2001,-V1(1),-P. 123-136

  217. Okazaki M., Hino K., Fujii К et al. Hepatic Fas-antigen expression before and after interferon therapy in patients with chronic hepatitis С // Dig. Dis. Sci. - 1996. - Vol.41. - P.2453-2458

  218. Oridate N., Lotan D., Mitchell M.F. et al. Inhibition of proliferation and induction of apoptosis in cervical carcinoma cells by retinoids: implications for chemoprevention. J Cell Biochem Suppl 1995; 23: 80-86

  219. Ormerod M.G., O'Neill C., Robertson D. et al. cis-Diammin-edichloroplatinum(II)-induced cell death through apoptosis in sensitive and resistant human ovarian carcinoma cell lines. Cancer Chemother Pharmacol 1996; 37: 5: 463-471

  220. Osaki M., Kase S.? Kodani I. et al. Expression of Fas and Fas ligand in human gastric adenomas and intestinal-type carcinomas: correlation with proliferation and apoptosis // Gastric cancer. - 2001. - Vol. 4. - N. 4. - P. 198-205

  221. Owen-Shaub L. Fas/APO-1: a cell surface protein mediating apoptosis // Cancer Bull. - 1994. -Vol. 46. - P. 141-145

  222. Pastorino J. G,, Tafani M., Rothman R. J. et al. Functional consequences of the sustained or transient activation by Bax of the mitochondrial permeability transition pore // The journal of biological chemistry. - 1999. - Vol. 274. - N. 44, - P. 31734-31739

  223. Pastorino J.G., Chen ST., Tafani M. et al. The overexpression of Bax produces cell death upon induction of the mitochondrial permeability transition. // J. Biol. Chem. -1998. - Vol.273. - P.7770-7775

  224. Patel T., Gores G.J., Steer C.J. Apoptosis and the liver:a mechanism of disease, growth regulation, and carcinogenesis// Hepatology. – 1999. – Vol. 30. –P. 811–815

  225. Reed J.C. Apoptosis-based therapies // Nat. Rev. Drug Discov. - 2002. - Vol.1. -N.2.-P.H1-121

  226. Reed J.C. Potential functions of Bcl-2 family proteins. // Advances in pharmacology. - 1997. -Vol.41. - P. 510-514

  227. Rehermann Bs Chang K, McHutchison JG. et al Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis С virus infection//J.Clin.Invest. 1996. 98.1432-1440

  228. Rivero V., Grespo J., Casafront F. Fulminant hepatitis by HBV. Role of Fas system. // Hepatology, —1998. —28 (Supple). —P. 482-483

  229. Rust C., Gores G.J. Apoptosis and liver disease // Am.J. Med. – 2000. – Vol. 108. – P. 567–574

  230. Ruvolo P.P., Deng X., May W.S. Phosphorylation of Bcl-2 and regulation of apoptosis//Leukemia.-2001.-Vol. 15.-N.4.-P. 515-522

  231. Sacco R.L., Benson R.T., Kargman D.E., et al. // High density lipoprotein cholesterol and ischemic stroke in the elderly, The northen Manhattan stroke study. // JAMA.2003. — 60(Suppl 1) — S31-48. 49

  232. Saegusa M., Kamata Y., Isono M., Okayasu I. Bcl-2 expression is correlated with a low apoptotic index and associated with progesterone receptor immunoreactivity in endometrial carcinomas. J Pathol 1996; 180: 3: 275-282

  233. Sanchez-Perez A.M., Soriano S., Clarke A.R., Gaston K. Disruption of the human papillomavirus type 16 E2 gene protects cervical carcinoma cells from E2F-induced apoptosis. J Gen Virol 1997; 78 (Pt 11): 3009-3018

  234. Sarraf С.E., Bowen I.D. Kinetic studies on a murine sarcoma and an analysis of apoptosis. Br J Cancer 1986; 54: 989-998

  235. Schendel S. L., Xie Z., Montal M. O. et al. Channel formation by antiapoptotic protein Bcl-2 // Proc. Natl. Acad. Sci. USA. - 1997. - Vol. 94. - P. 5113-5118

  236. Schlesinger P. H., Gross A., X.-M. Yin et al. Comparison of the ion channel characteristics of proapoptotic Bax and antiapoptotic Bcl-2 // Proc. Natl. Acad. Sci. USA. -1997. -Vol. 94. -P. 11357-11362

  237. Sheets E.E., Crum C.P., Yeh J. Association between cervical neoplasia and apoptosis as detected by in situ nuclear labeling. Gynecol Oncol 1996; 63: 1: 94-100

  238. Sheets E.E., Yeh J. The role of apoptosis in gynaecological malignancies. Ann Med 1997; 29: 2: 121-126

  239. Shigekazu N. Apoptosis by death factor. Cell 1997; 88: 355-365

  240. Shilkaitis A., Graves J., Mehta R. R. et al. Bcl-2 and Bax are differentially expressed in hyperplastic premalignant and malignant lesions of mammary carcinogenesis // Cell Growth Differ. - 2000. - Vol. 11. - P. 437-445

  241. Shimizu S., Konishi A., Kodama T. et al, BH4 domain of antiapoptotic Bcl-2 family members closes voltage dependent anion channel and inhibits apoptotic mitochondrial changes and cell death // Proc. Natl. Acad. Sci. USA. - 2000. - Vol. 97. - N. 7. - P. 3100-3105

  242. Shimizu S., Tsujimoto Y. Proapoptotic ВНЗ-only Bcl-2 family members induce cytochrome с release, but not mitochondnal membrane potential loss, and do not directly modulate voltage-dependent anion channel activity // Proc. Natl. Acad. Sci. USA. -2000. -VoI.97.-N. 2.-P. 577-582

  243. Shinoura N., Yoshida Y., SadataA. et al. Apoptosis by retrovirus- and adenovirus-mediated gene transfer of Fas ligand to glioma cells; implications for gene therapy // Hum. Gene Ther. —1998. - Vol. 9, N 14. - P. 1983-1993

  244. Shoji Y., Saegusa M., TakanoY. et al. Correlation of apoptosis with tumour cell differentiation, progression, and HPV infection in cervical carcinoma. J Clin Pathol 1996; 49: 2: 134-138

  245. Siegel RM.,. Frederiksen J K., Zacharias D A., et al. Fas pre-association required for apoptosis signaling and dominant inhibition by pathogenic mutationsZ/Science. -2000. -Vol. 288. -P.2354-2357

  246. Silvestrini R., Veneroni S., Daidone M. G. et al. The Bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymph node negative breast cancer patients // J. Natl. Cancer Inst. - 1994. - Vol. 86. - P. 499-504

  247. Sinkovics J. G., Horvath J. Can virus therapy of human cancer be improved by apoptosis induction? // Med. Hypothes. —1995. - Vol. 44, N 5. - P. 359-368

  248. Smith A.E. Gene therapy - where are we // The Lancet. - 1999. - V.354. (Suppl. l).-P. l-4

  249. Socie G., Mary J -Y.t Lemann M. Et al.Prognostic value of apoptotic cells and infiltrating neutrophils in graft-versus-host disease of the gastrointestinal tract in humans: TNF and Fas expression // Blood. - 2004. - V. 10. - P. 50-57

  250. Soini Y., Paakko P. Extent of apoptosis in relation to p53 and bcl-2 expression in germ cell tumors. Human Pathol 1996; 27: 11: 1221-1226

  251. Spinozzi F., Forenza N., Agen E. et al. CD30 Th2 allergen-specific Y T lymphocytes are increased in bronchoalveolar lavage (BAL) fluid of allergic asthma patients and sensitive to steroid-induced apoptosis. Eur Resp J 1995; 8: Suppl 19: 1874

  252. Sprinzl M.F., Rosset S., Male F.-F. et al. Chronic viral infections causes an apoptosis resistant hepatocellular phenotype by induction of regeneration factors of the liver // Strack P.R. Apoptosis mediated by HIV protease is preceded by cleavage of Bcl-2 // Proc.Natl. Acad. Sci. USA, 1996, v. 93, P. 9571-9576

  253. Su F., Schneider R.J. Hepatitis B virus HBx protein sensitizes cells to apoptotic killing by tumor necrosis factoralpha // Proc. Natl. Acad. Sci. USA. – 1997. –Vol. 94. – P. 8744–8749

  254. Su F., Schneider R.J. Hepatitis В virus HBx protein sensitizes cells to apoptotic killing by tumor necrosis factor alpha/TProc NatI Acad Sci 1997, 94(16), 8744-8749

  255. Sun X.-M., Bratton S. B„ Butterworth M. et al. Bcl-2 and Bcl-XL Inhibit CD95-mediated apoptosis by preventing mitochondrial release of Smac/DIABLO and subsequent inactivation of X-linked inhibitor-of-apoptosis protein II The journal of biological chemistry. -2002. -Vol. 277. -P. 11345-11351

  256. Tao X.-J., Tilly K. I., Maravei D. V. Differential expression of members of the Bcl-2 gene family in proliferative and secretory human endometrium glandular epithelial cell apoptosis is associated with increased expression of Bax // Journal of clinical endocrinology and metabolism. - 1997. - Vol. 82. - N. 8. - P. P2738-P2746

  257. Tecchio C, Huber V., Scapini P. et al. IFN-stimulated neutrophils and monocytes release a soluble form of TNF-related apoptosis-inducing ligand (TRAIL/Apo-2 ligand) displaying apoptotic activity on leukemic cells // Blood. - 2004. -V. 103.-P. 3837-3844

  258. Terradillos O, Pollicino T, Lecoeur H. p53-independent apoptotic effects of the hepatitis В virus HBx protein in vivo and in vitro//Oncogene 1998, 17(16). 2115-2123

  259. Thompson C. B. Apoptosis in the pathogenesis and treatment of disease. Science.,1995.- 5203.- 1456-1462

  260. Tokano Y., Miyake S., Kayagaki., N et al. Soluble Fas molecule in serum of patients with systemic lupus erythematosus// J Clin immunol . -1996. -Vol.16. -P.261-265

  261. Toubi E., Kessel A., Goldstein L. et al. Enhanced peripheral T-cell apoptosis in chronic hepatitis C virus infection: association with liver disease severity //J. Hepatol. – 2001. – Vol. 35. – P. 774–780

  262. Trauth B.C., Klas C., Peters A.M.J. et al. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 1989; 245: 2: 301

  263. Ueda M., Kumagai K., Ueki K. et al. Growth inhibition and apoptotic cell death in uterine cervical carcinoma cells induced by 5-fluorouracil. Int J Cancer 1997; 71: 4: 668-674

  264. Uslu R., Jewett A., Bonavida B. Sensitization of human ovarian tumor cells by subtoxic CDDP to antifas antibody-mediated cytotoxicity and apoptosis. Gynecol Oncol 1996; 62: 2: 282-291

  265. Vaux D.L., Strasser A. The molecular biology of apoptosis // Proc. Natl. Acad. Sci. 1996,v.93, P. 2239-2244

  266. Wagenaar-Miller R,A,, Gorden L., Matrisian L.M. Matrix metalloproteinases in colorectal cancer: Is it worth talking about?// Cancer and metastases reviews.-2004.-V.23.-P. 119-135

  267. Wang X. The expanding role of mitochondria in apoptosis // Genes Dev. - 2001. -Vol. 15.-N,22.-P. 2922-2933

  268. Wang Z.H., Ding M.X., Chew S.B. et al. Bcl-2 and Bax proteins are nuclear matrix associated proteins.// Anticancer Res - 1999. - Vol.19. - P.5445-5450

  269. Werner A.B., Vries E., Tait S.W.G. et al. Bcl-2 family member Bfl-l/Al sequesters truncated Bid to inhibit its collaboration with pro-apoptotic Bak or Bax // The journal of biological chemistry. - 2002. - Vol. 277. - P. 22781-22788

  270. Werner A.B., Vries E., Tait S.W.G. et al. TRAIL receptor and CD95 signal to mitochondria via FADD, caspase-8/10, Bid, and Bax but differentially regulate events downstream from truncated Bid // The journal of biological chemistry. - 2002. - Vol. 277. - P. 40760-40767

  271. Wheeler J.A., Stephens L.C., Tornos C. et al. ASTRO Research Fellowship: apoptosis as a predictor of tumor response to radiation in stage IB cervical carcinoma. American Society for Therapeutic Radiology and Oncology. Int J Radiat Oncol Biol Phys 1995; 32: 5: 1487-1493

  272. White E. Regulation of apoptosis by transforming genes of the DNA tumor virus adenovirus//Proc. Soc. Exp. Biol. Med. 1993, 204(1), P. 30-39

  273. Yamamoto K., Ichijo H., Korsmeyer S. J. BcI-2 is phosphorylated and inactivated by an ASKl/Jun N-terminal protein kinase pathway normally activated at G2/M // Molecular and cellular Biology. - 1999. - Vol. 19. - N. 12. - P. 8469-8478

  274. Yamasaki F., Tokunaga O., Sugimori H. Apoptotic index in ovarian carcinoma: correlation with clinicopathologic factors and prognosis. Gynecol Oncol 1997; 66: 3: 439-448

  275. Yang H.B., Chow N.H., Sheu B.S. et al. The role of Bcl-2 in the progression of the colorectal adenoma-carcinoma sequence // Anticancer Res. - 1999. - Vol. 19. - N. IB.-P. 727-730

  276. Yang J., Liu X., Bhalla K. Et al. Prevention of apoptosis by Bcl-2: release of cytochrome с from mitochondria blocked // Science. - 1997. - Vol. 275. - P. 1129-1132

  277. Yunehara S., Nishimura Y., Kishi S., Ishii A. Expression and function of apoptosis antigen Fas on T cells in thymus and peryphery. Tiss antigens 1993; 42: 4: 253

  278. Zhang H., Holzgreve W., Geyter C. Bcl-2-L-10, a novel anti-apoptotic member of the Bcl-2 family, blocks apoptosis in the mitochondria death pathway but not in the death receptor pathway // Human Molecular Genetics. - 2001. - Vol, 10. - N. 21. - P. 2329-2339

  279. Zhang H., Xu Q., Krajewski S. et al. Bar: An apoptosis regulator at the intersection of caspases and Bcl-2 family proteins // Proc. Natl. Acad. Sci. USA. - 2000. - Vol. 97. - P. 2597-2602

  280. Zhu N., Khoshnan A, Schneider R. et al. Hepatitis С virus core protein binds to the cytoplasmic domain of TNF receptor 1 and enhances TNF-induced apoptosis// J.Virol. 1998, 72(5), 3691-3697


Приложение 1 Отчет о патентных исследованиях




Приложение 2




1   ...   7   8   9   10   11   12   13   14   15

  • Приложение 1 Отчет о патентных исследованиях